# C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

> **NCT07250724** · — · RECRUITING · sponsor: **Bactolife A/S** · enrollment: 60 (estimated)

## Conditions studied

- Clostridioides Difficile Infection Recurrence

## Interventions

- **OTHER:** Participants that are undergoing standard of care antibiotic treatment for their second C. Diff infection will be followed for 8 weeks after completing antibiotic treatment.

## Key facts

- **NCT ID:** NCT07250724
- **Lead sponsor:** Bactolife A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2026-10-15
- **Final completion:** 2026-10-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07250724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07250724, "C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07250724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*